CCDC66 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.372200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.635600E-01
Normal-vs-Stage2
1.110080E-02
Normal-vs-Stage3
3.875600E-02
Normal-vs-Stage4
2.580600E-01
Stage1-vs-Stage2
3.946200E-02
Stage1-vs-Stage3
3.436100E-02
Stage1-vs-Stage4
4.465200E-01
Stage2-vs-Stage3
5.343500E-02
Stage2-vs-Stage4
6.205600E-01
Stage3-vs-Stage4
4.774300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.488300E-02
Normal-vs-AfricanAmerican
5.052400E-02
Normal-vs-Asian
2.195700E-02
Caucasian-vs-AfricanAmerican
3.656400E-01
Caucasian-vs-Asian
2.506000E-01
AfricanAmerican-vs-Asian
9.594200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.730500E-02
Normal-vs-Female
2.954200E-02
Male-vs-Female
9.230200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.386200E-01
Normal-vs-Age(41-60Yrs)
2.392300E-02
Normal-vs-Age(61-80Yrs)
2.947500E-02
Normal-vs-Age(81-100Yrs)
3.428100E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.700400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.158400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.692570E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.204020E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.169400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.862200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.715700E-02
Normal-vs-Daily Drinker
2.140800E-01
Normal-vs-Weekly Drinker
2.515000E-01
Normal-vs-Occasional Drinker
3.151900E-02
Normal-vs-Social Drinker
8.849900E-02
Non Drinker-vs-Daily Drinker
1.988790E-01
Non Drinker-vs-Weekly Drinker
6.519400E-01
Non Drinker-vs-Occasional Drinker
6.569600E-01
Non Drinker-vs-Social Drinker
6.860600E-01
Daily Drinker-vs-Weekly Drinker
4.594600E-01
Daily Drinker-vs-Occasional Drinker
4.942200E-01
Daily Drinker-vs-Social Drinker
1.292400E-01
Weekly Drinker-vs-Occasional Drinker
9.945800E-01
Weekly Drinker-vs-Social Drinker
4.494000E-01
Occasional Drinker-vs-Social Drinker
4.730200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.942000E-01
Normal-vs-Grade 2
1.629220E-01
Normal-vs-Grade 3
6.486800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.446000E-01
Grade 1-vs-Grade 3
4.639600E-01
Grade 1-vs-Grade 4
3.942000E-01
Grade 2-vs-Grade 3
5.482600E-01
Grade 2-vs-Grade 4
1.629220E-01
Grade 3-vs-Grade 4
6.486800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.257650E-02
Normal-vs-NonDiabetic
1.735590E-02
Diabetic-vs-NonDiabetic
6.786400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.152100E-02
Normal-vs-NoPancreatitis
1.479520E-02
Pancreatitis-vs-NoPancreatitis
8.545000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.353990E-01
Normal-vs-N1
6.340000E-03
N0-vs-N1
2.811400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.638000E-01
Normal-vs-TP53-NonMutant
2.545600E-01
TP53-Mutant-vs-TP53-NonMutant
6.977200E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
